Skip to search formSkip to main contentSkip to account menu

bouchardatine

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Non‐alcoholic hepatic fatty liver disease (NAFLD) is a manifestation of the metabolic syndrome in the liver and non‐alcoholic… 
2019
2019
BACKGROUND AND PURPOSE Non-alcoholic hepatic fatty liver disease (NAFLD) is a manifestation of metabolic syndrome (MetS) in liver… 
2018
2018
Inhibition of the differentiation of adipocytes and reduced lipid synthesis are efficacious approaches for treating obesity… 
2017
2017
Promoting energy metabolism is known to provide therapeutic effects for obesity and associated metabolic disorders. The present… 
2015
2015
Our recent study has shown that the natural product bouchardatine (1) can reduce the triglyceride (TG) content in 3T3-L1… 
2011
2011
  • M. Bubenyák
  • Acta pharmaceutica Hungarica
  • 2011
  • Corpus ID: 27009155
Quinazolinocarboline rutaecarpine and evodiamine (Evodia rutaecarpa) are main alkaloid components of traditional Chinese folk…